Sorry, you need to enable JavaScript to visit this website.

Scientific opinion on the substantiation of health claims related to fructooligosaccharides (FOS)

Scientific opinion on the substantiation of health claims related to fructooligosaccharides (FOS)

This opinion addresses the scientific substantiation of health claims in relation to fructooligosaccharides (FOS) from sucrose.

1 min read

On the basis of the data presented, the Panel concludes that a cause and effect relationship has not been established between the consumption of fructooligosaccharides from sucrose and the maintenance of normal (fasting) blood concentrations of triglycerides

Reference

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to fructooligosaccharides (FOS) from sucrose and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 774), changes in short chain fatty acid (SCFA) production and pH in the gastrointestinal tract (ID 775), changes in bowel function (ID 775, 778), reduction of gastrointestinal discomfort (ID 775, 778), increase in calcium and/or magnesium absorption leading to an increase in magnesium and/or calcium retention (ID 776, 777), maintenance of normal blood LDL-cholesterol concentrations (ID 805) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 805) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2011;9(4):2023. [25 pp.]. doi:10.2903/j.efsa.2011.2023.